Abstract

Using telemedicine technologies as a tool for monitoring adverse events in patients with chronic hepatitis C receiving antiviral therapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call